Business Description
Bruker Corp
NAICS : 334516
SIC : 3826
ISIN : US1167941087
Share Class Description:
MEX:BRKR: Ordinary SharesTotal Employee Number:
11,085Description
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.77 | |||||
Debt-to-EBITDA | 6.78 | |||||
Interest Coverage | 4.33 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.77 | |||||
Beneish M-Score | -2.4 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.1 | |||||
3-Year EBITDA Growth Rate | -16.9 | |||||
3-Year EPS without NRI Growth Rate | -7.9 | |||||
3-Year FCF Growth Rate | -54.4 | |||||
3-Year Book Growth Rate | 28.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.85 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.18 | |||||
Days Inventory | 223.89 | |||||
Days Sales Outstanding | 56.47 | |||||
Days Payable | 43.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | 4.38 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.42 | |||||
Operating Margin % | 7.6 | |||||
Net Margin % | -2.04 | |||||
EBITDA Margin % | 7.69 | |||||
FCF Margin % | 1.92 | |||||
OCF Margin % | 5.51 | |||||
ROE % | -3.09 | |||||
ROA % | -1.14 | |||||
ROIC % | 4.61 | |||||
ROC (Joel Greenblatt) % | 3.01 | |||||
ROCE % | 0.79 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 19.06 | |||||
PE Ratio without NRI | 37.48 | |||||
Shiller PE Ratio | 40.46 | |||||
PS Ratio | 2.48 | |||||
PB Ratio | 3.65 | |||||
Price-to-Tangible-Book | 103.68 | |||||
Price-to-Free-Cash-Flow | 134.46 | |||||
Price-to-Operating-Cash-Flow | 45.61 | |||||
EV-to-EBIT | 264.51 | |||||
EV-to-Forward-EBIT | 16.76 | |||||
EV-to-EBITDA | 38.42 | |||||
EV-to-Forward-EBITDA | 14.3 | |||||
EV-to-Revenue | 2.96 | |||||
EV-to-Forward-Revenue | 2.66 | |||||
EV-to-FCF | 160.35 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 2.66 | |||||
Price-to-Median-PS-Value | 0.78 | |||||
Price-to-Graham-Number | 13.14 | |||||
Earnings Yield (Greenblatt) % | 0.38 | |||||
FCF Yield % | 0.74 | |||||
Forward Rate of Return (Yacktman) % | -7.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bruker Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 62,764.156 | ||
| EPS (TTM) (MXN) | -12.539 | ||
| Beta | -0.4291 | ||
| 3-Year Sharpe Ratio | -1.2 | ||
| 3-Year Sortino Ratio | -1.26 | ||
| Volatility % | 28.84 | ||
| 14-Day RSI | 87.67 | ||
| 14-Day ATR (MXN) | 0.000007 | ||
| 20-Day SMA (MXN) | 705 | ||
| 12-1 Month Momentum % | 13.53 | ||
| 52-Week Range (MXN) | 615 - 715 | ||
| Shares Outstanding (Mil) | 152.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bruker Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bruker Corp Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-12 08:30 | In 185 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-12 | In 184 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-03 08:30 | In 84 days | ||
| Third quarter earnings results for 2026 | 2026-11-03 | In 83 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 09:00 | 705.00 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 | 705.00 (+0.00%) | ||
| USD 0.050000 Cash Dividend | 2026-06-22 | 705.00 (+0.00%) | ||
| General meeting for 2026 | 2026-05-21 10:00 | 705.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 08:00 | 705.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 705.00 (+0.00%) |
Show
Entries
Bruker Corp Frequently Asked Questions
What is Bruker Corp(MEX:BRKR)'s stock price today?
The current price of MEX:BRKR is MXN705.00. The 52 week high of MEX:BRKR is MXN715.00 and 52 week low is MXN615.00.
When is next earnings date of Bruker Corp(MEX:BRKR)?
The next earnings date of Bruker Corp(MEX:BRKR) is 2026-11-03 Est..
Does Bruker Corp(MEX:BRKR) pay dividends? If so, how much?
Bruker Corp(MEX:BRKR) does not pay dividend.
Press Release
Articles on Bruker Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers